Topics
Pharmacology
Febuxostat-associated rhabdomyolysis in chronic renal failure
Statin therapy in patients with chronic kidney disease can be risky
Debasish Ghosh MB BS · Philippa M McGann BPharm · Timothy J Furlong PhD, FRACP · Richard O Day MD, FRACP
Knowing when to stop antibiotic therapy
Improving use of antimicrobials in Australia requires change in doctors’ practice and PBS arrangements
Angus J Thompson BPharm(Hons), MSc, CGP · Ivan Bindoff BComp(Hons), PhD · Andrew C Stafford BPharm(Hons), PhD, AACPA
The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?
The ABC’s Catalyst program criticising statins affected people’s willingness to take these important drugs
Andrea L Schaffer BSc(Hons), MSc, MBiostat · Nicholas A Buckley BMed, FRACP, MD · Timothy A Dobbins BMath, PhD · Emily Banks MB BS, PhD, FAFPHM · Sallie-Anne Pearson BSc(Hons), PhD
Proton pump inhibitors: too much of a good thing?
A new suite of free resources supports their quality use
Lynn M Weekes
Warfarin-induced skin necrosis following recommencement of warfarin after perioperative Prothrombinex-VF
Warfarin-induced skin necrosis is a rare complication of a commonly used medication
Ryan M O’Dempsey MB BS, BPhty · Andrew MTL Choong MB BS, FRCS, FEBVS · Amit Patel MRCP(UK), MRCS(Eng), PhD · Jason Miller MB BS, FRACS(Gen) · Philip J Walker MB BS, FRACS(Vasc) · Allan Kruger MB BS, FRACS(Vasc), DDU
The trumpet's blown pupil
A gardener experiences the power of an ancient alkaloid
Chris Plummer FRACP, PhD · Adam Dangoor MRCP, MD
A prospective cohort study of trends in self-poisoning, Newcastle, Australia, 1987–2012: plus ça change, plus c’est la même chose
A massive increase in antidepressant prescriptions has had little impact on rates of self-harm or antidepressant poisoning
Nicholas A Buckley BMed, FRACP, MD · Ian M Whyte MB BS(Hons), FRACP, FACMT · Andrew H Dawson MB BS, FRCP, FRACP · Geoffrey K Isbister BSc, FACEM, MD
Polypharmacy among inpatients aged 70 years or older in Australia
Data reveal levels of polypharmacy that may suggest a lack of attempts to deprescribe when appropriate
Ruth E Hubbard MSc, MD, FRACP · Nancye M Peel PhD, MPH, BPhty · Ian A Scott FRACP, MHA, MEd · Jennifer H Martin FRACP, MA, PhD · Alesha Smith PhD, MSc, BSc · Peter I Pillans MB BCh, FRACP, MD · Arjun Poudel MScPharm · Leonard C Gray PhD, FRACP, FACHSM
First use of creatine hydrochloride in premanifest Huntington disease
A potentially important option for patients with Huntington disease that warrants further study
Chris Tuckfield MB BS(Hons), MPhil
New and emerging treatments for Parkinson disease
The main aim is to maintain quality of life throughout the illness
Victor S C Fung MB BS, PhD, FRACP
Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchange
Conservative management avoids the morbidity and costs associated with plasma exchange
Courtney Tate MB BS, PhD, BSc(Hons) · Peter Mollee MMedSc, FRACP, FRCPA
Stable post-TRUS biopsy sepsis rates and antibiotic resistance over 5 years in patients from Newcastle, New South Wales
Screening with cultures from rectal swabs before prostate biopsy is not indicated
George Mirmilstein MB BS(Hons) · John Ferguson DTM
First do no harm: a real need to deprescribe in older patients
Medication reviews and multidisciplinary input prevent harm
Lisa Kouladjian BMedSc(Hons), MPharm, AACPA · Timothy F Chen PhD, DipHPharm, BPharm · Sarah N Hilmer MB BS(Hons), FRACP, PhD
Antibiotic prescribing practice in residential aged care facilities — health care providers' perspectives
In reply: Our focus was the providers’ perspectives, but we acknowledge the importance of the consumer alongside
Ching Jou Lim BPharm(Hons), PhD · Megan W-L Kwong MB BS, BMedSci · David C M Kong PhD, BPharm, MPharm
Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement
Expansion of intellectual property rights will further increase the cost of medicines in Australia
Deborah H Gleeson PhD, MPH, GradDipHealthProm · Hazel Moir PhD, EMA, BA(Hons) · Ruth Lopert BMed, MMedSci, FAFPHM
Knowing when to stop antibiotic therapy
Empirical antibiotic therapy that turns out to be unnecessary, on review, can (and should) be stopped immediately
Gwendolyn L Gilbert MD, FRACP, MBioethics
The effect of fasting diets on medication management
Adverse effects of medication and therapeutic failure are possibilities in patients who are fasting
Gina McLachlan BPharm, MClinPharm · The-Phung To BPharm, MClinPharm
Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction
There is growing evidence that medications with anti-TNF-alpha activity may have a role in immunocompetent individuals
James S Molton MB BS, BSc, FRACP · Paul J Huggan BSc(Hons), MB ChB · Sophia Archuleta MD
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial
Assessing comprehensive combination therapy from the perspective of the Australian health system
Tracey-Lea Laba PhD, BPharm(Hons), BSc(Hons) · Alison Hayes BSc(Hons), PhD · Serigne Lo PhD · David P Peiris MIPH, PhD, FRACGP · Tim Usherwood MD, FRACGP, FRCP · Graham S Hillis MB ChB, PhD · Natasha Rafter MPH, FAFPHM, NZCPHM · Christopher M Reid PhD · Andrew M Tonkin MD, FRACP, FCSANZ · Ruth Webster BMedSc(Hons), MB BS(Hons), MIPH(Hons) · Bruce C Neal MB ChB, PhD, FRCP · Alan Cass BA, FRACP, PhD · Anushka Patel SM, PhD, FRACP · Anthony Rodgers MB ChB, PhD · Stephen Jan BEc, MEc, PhD
The transition from hospital to primary care for patients with acute coronary syndrome: insights from registry data
Data from three registries illustrate gaps in secondary prevention after discharge from hospital
Julie Redfern PhD, BAppSc(Hons), BSc · Tom G Briffa PhD
Optimising pharmacotherapy for secondary prevention of non-invasively managed acute coronary syndrome
What is the ideal post-hospital therapy for patients who do not receive coronary revascularisation?
Peter L Thompson MD, FRACP, FACC · Angus G Thompson PhD, MB BS, FRACP · Chris Judkins MB BS, MClinRes, FRACP
Cytomegalovirus disease in immunocompetent adults
The incidence of severe disease is low, but it may present a significant diagnostic challenge
Daniel Lancini · Helen M Faddy BSc(Hons), PhD · Robert Flower PhD · Chris Hogan MB BS, BSc(Hons), FRCPA
Death due to intravenous use of α-pyrrolidinopentiophenone
A case that highlights the limitations of commonly available drug screens
Kate Sellors BMed, FACEM, GCertClinTox · Alison Jones MD, FRACP, FAACT · Betty Chan MB BS(Hons), PhD, FACEM
Antibiotic prescribing practice in residential aged care facilities — health care providers' perspectives
n/a
Ching Jou Lim BPharm(Hons) · Megan W-L Kwong MB BS, BMedSci · Rhonda L Stuart MB BS, FRACP, PhD · Kirsty L Buising MPH, MD, FRACP · N Deborah Friedman FRACP, MD, MPH · Noleen J Bennett PhD, MPH · Allen C Cheng FRACP, MPH, PhD · Anton Y Peleg MB BS, PhD, FRACP · Caroline Marshall FRACP, PhD, GradDipClinEpi · David C M Kong BPharm, MPharm, PhD
Lithium-induced thyrotoxicosis in a patient with treatment-resistant bipolar type I affective disorder
Lithium has profound effects on thyroid physiology
Santhi Chalasani MB BS(Hons) · Katherine A Benson MB BS(Hons), FRACP